{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:51:39Z","timestamp":1787784699971,"version":"build-2784847793"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jdcr.2025.11.001","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T05:08:46Z","timestamp":1762578526000},"page":"110-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment: A case series study"],"prefix":"10.1016","volume":"67","author":[{"given":"Abigail","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina April","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4347-0710","authenticated-orcid":false,"given":"Nicholas","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2882-0242","authenticated-orcid":false,"given":"Angela J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.jdcr.2025.11.001_bib2","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.3390\/cancers13215556","article-title":"Cancer-related alopecia: from etiologies to global management","volume":"13","author":"Quesada","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.jdcr.2025.11.001_bib3","first-page":"186","article-title":"Hair loss during and after breast cancer therapy","volume":"31","author":"Rose","year":"2023","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jdcr.2025.11.001_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jdcr.2023.02.021","article-title":"Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer","volume":"35","author":"Dubin","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"5","key":"10.1016\/j.jdcr.2025.11.001_bib5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","article-title":"Hair disorders in patients with cancer","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2025.11.001_bib6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy-induced alopecia in patients with breast cancer","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2025.11.001_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5301\/tj.5000376","article-title":"Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?","volume":"101","author":"Moscetti","year":"2015","journal-title":"Tumori"},{"issue":"9","key":"10.1016\/j.jdcr.2025.11.001_bib8","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00403-023-02660-z","article-title":"Retrospective review of oral and topical minoxidil for cancer treatment-induced hair loss","volume":"315","author":"Minta","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"10.1016\/j.jdcr.2025.11.001_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update","volume":"83","author":"Devjani","year":"2023","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.jdcr.2025.11.001_bib10","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaad.2022.12.005","article-title":"Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: a retrospective cohort study","volume":"88","author":"Kang","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.11.001_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-018-4996-3","article-title":"Safety of 5\u03b1-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies","volume":"174","author":"Rozner","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.jdcr.2025.11.001_bib12","first-page":"414","article-title":"Side effects related to 5 \u03b1-Reductase inhibitor treatment of hair loss in women: a review","volume":"15","author":"Seale","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"10.1016\/j.jdcr.2025.11.001_bib13","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.3390\/jcm13113052","article-title":"Safety of antiandrogens for the treatment of female androgenetic alopecia with respect to gynecologic malignancies","volume":"13","author":"Seyed Jafari","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.jdcr.2025.11.001_bib14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s13555-020-00448-x","article-title":"Efficacy and safety of oral minoxidil 5 mg once daily in the treatment of Male patients with androgenetic alopecia: an open-label and global photographic assessment","volume":"10","author":"Panchaprateep","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jdcr.2025.11.001_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jdrv.2024.08.002","article-title":"Minoxidil-induced hypertrichosis: pathophysiology, clinical implications, and therapeutic strategies","volume":"2","author":"Desai","year":"2024","journal-title":"JAAD Rev"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625006010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625006010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:30:51Z","timestamp":1768552251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625006010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":14,"alternative-id":["S2352512625006010"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.11.001","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment: A case series study","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}